21498-Lung Cancer-NA-126

Lung Cancer

A Phase 1/2 Study of Avutometinib (VS-6766) in Combination with Sotorasib in Patients with KRAS G12C mutant Non-Small Cell Lung Cancer (NSCLC) (RAMP 203) (VS-6766-203)

  • Details

ClinicalTrials.gov ID: NCT05074810
Diagnosis Type: NA
USOR Number:

  • Address

4700 E Hale Parkway, Suite 400
Denver, CO 80220
P: (303) 321-0302

Search by practice name, trial titles, indicators and specific disease types.